For their part, operators are committed to the Federal Reserve (Fed) Continue with cuts in interest rates this year, in addition to the growing enthusiasm existing around the artificial intelligencewhich maintains to some extent the expectations of the investment sector.
In this context, the Dow Jones index of industrialists rose 0.18% to 46,397.83 points; The S&P500 won 0.39% to 6,687.06 points and Nasdaq Composite showed 0.31% to 22,660.01 points
For its part September it was a positive month for the reference indices in which Dow Jones won a 1.8% S&P500 rose 3% and Nasdaq Composite advanced 5.6%.
The US is aimed at a government closure
The US government will come into closure if Congress does not extend financing beyond Tuesday. The vice president JD Vance declared to the press on Monday that this scenario seemed likely after the conversations between the president Donald Trump and bipartisan leaders will show few advances.
The current political stagnation focuses on disagreements on health spending and social welfare programs. While Republicans have a majority of 53 seats in the Senate, they still need 60 votes to advance an expense bill.
Historically, government closures had little impact on corporate gains. However, they tend to disturb economic activity. The last time the Government was paralyzed was for a period of 35 days between the end of 2018 and early 2019.
The Congress Budget Office estimated that the closure reduced the Gross Domestic Product (GDP) in approximately US $ 11 billion.
A closure this week could delay the publication of non -agricultural payroll data in Septemberthat will be published on Friday and that are followed widely as a guide for possible future feat cuts of the Fed.
The data of non -agricultural employment vacancies (Jolts) of August, voluntary resignations, hiring and layoffs will be published later in the session and could give an idea of the current strength of the labor market.
More tariffs on the way with a hurry and without pause
In addition to the uncertainty about a possible closure of the government, Investors also have to deal with a new wave of business -related holders.
Trump imposed tariffs on the importation of wood, furniture and cooking accessories with the intention of promoting local production and reducing import dependence.
In a proclamation on Monday, The president imposed a 10% tariff on soft wood and sawn wood importsa 25% tariff to the imports of cabinets and kitchen dressers, and a 25% tariff to upholstered wood products.
Tariffs will take effect as of October 14, according to Trump. The encumbrances are based on the conclusions of an investigation by the Department of Commerce on imports of wood and furniture, which Trump ordered earlier this year.
The outstanding actions of Wall Street
ATKORE INC. They rose 3.4% after Bloomberg reported that activist investor Irenic Capital Management acquired a 2.5% participation in the electrical manufacturing company and press for a possible sale.
SCISPARC LTD. It shot 35.4% on Tuesday after N2Off shareholders, Inc. approved the proposal for the acquisition of the SCISPARC subsidiary with majority participation, Pizarx Bio LTD.
The approval, which occurred during the N2OFF special meeting on September 25, 2025, represents a crucial milestone to complete the acquisition that would make Mitococarex a total property subsidiary of N2OFF.
NLS Pharmaceutics Ag It fell 25.3% after shareholders approved a fusion with the Israeli Cell Therapy company Kadimage Ltd (+5.4%).
The Swiss biopharmaceutical company in clinical phase, focused on central nervous system disorders, saw their actions fall while investors assimilated the details of the transaction. The approval eliminates the last corporate obstacle before closing, which will result in the price of the company combined in Nasdaq as Newcelx Ltd. under the “NCEL” ticket.
Exchange agreement: Pfizer Drive Trump Medicines remove tariffs
Pfizer Inc. (+6.8%) reached an agreement with the administration of President Trump to avoid tariffs on pharmaceutical products for three years in exchange for reducing the prices of certain medications in the US.
As part of the agreement, Pfizer will sell some products with an average discount of 50% through a direct website to the consumer called Trumprxwhich allows Americans to pay in cash for medicines to discount fees negotiated by the Government.
The agreement protects Pfizer from possible 100% tariffs that Trump threatened to impose, while also protects the research company of Section 232 of the Administration on whether the costs of the medicines represent a threat to national security.
The executive director of Pfizer, Albert Bourlaconfirmed the agreement, which includes providing “more favored nation” prices in some drugs for Americans registered in Medicaid insurance programs. This approach is aligned with Trump’s repeated demands that companies equate US prices with what foreign countries pay. The agreement includes significant discounts on specific medications.
President Trump argued that Americans pay more than three times what other nations of the Organization for Economic Cooperation and Development pay for brand drugs, even after considering the US discounts.
The administration indicates that, although the US has less than 5% of the world’s population, approximately 75% of global pharmaceutical profits come from US taxpayers.
The agreement with Pfizer follows the executive order of Trump of May 12 entitled “Delivering drug prices with a more favored nation recipe to American patients” and its July 31 letters to pharmaceutical manufacturers describing steps to reduce medication prices in the country.
Source: Ambito
I am a 24-year-old writer and journalist who has been working in the news industry for the past two years. I write primarily about market news, so if you’re looking for insights into what’s going on in the stock market or economic indicators, you’ve come to the right place. I also dabble in writing articles on lifestyle trends and pop culture news.
